Scientists studying biomarkers associated with human diseases and drug responses commonly use targeted immunoassays for marker detection and quantitation. Challenges associated with conventional ...

The measurement of specific molecules in serum and plasma is essential in the diagnosis, treatment and management of many diseases. Traditional methods have used single assay techniques, whereby only ...

The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly ...

Multiplex assay technology allows researchers to obtain quantitative data for all these key factors at once from a precious micro-sample (e.g., mouse serum, tissue lavage fluid, or cell culture ...

At virtually every stage of the processes required to bring a new drug to market—from early discovery through clinical trials—biopharma scientists would like more information. More insight into the ...

The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...

SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company® ...

REDDING, Calif., Aug. 6, 2024 /PRNewswire/ -- According to a new market research report titled, 'Multiplex Assays Market Size, Share, Forecast, & Trends Analysis by Type (Protein [Bead, Planar], ...